Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Registos relacionados

• FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
  Por: Griffiths, G, et al.
  Publicado em: (2009)
• FRAGMATIC: A randomised phase III clinical trial investigating the effect of <b>fragm</b>in^®<b>a</b>dded to standard <b>t</b>herapy <b>i</b>n patients with lung <b>c</b>ancer
  Por: Macbeth Fergus R, et al.
  Publicado em: (2009-10-01)
• Releasing interim results from a randomised clinical trial: an example from the QUARTZ trial
  Por: Nankivell Matthew, et al.
  Publicado em: (2011-12-01)
• Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
  Por: Dong Qian, et al.
  Publicado em: (2015-01-01)
• Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial
  Por: Anders Kjellberg, et al.
  Publicado em: (2023-01-01)